Related Articles
Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report
Late‑onset immune checkpoint inhibitor‑related pneumonitis after cessation of sintilimab: A case report and literature review
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis
Anti‑PD‑1 immune checkpoint inhibitor inducing endocrine toxicity in a patient with advanced lung cancer: A case report and literature review
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report